FEATURED/ARCHIVES (28/04/24)
Cost-Effectiveness of Implementing Smoking Cessation Interventions for Patients with Cancer · June 2022
Articles
JAMA Network Open
Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach · May 2023
Articles
ClinicoEconomics and Outcomes Research
Cost-Effectiveness of Alcohol Use Treatments among Patients with Alcohol-Related Cirrhosis · December 2020
Articles
Journal of Hepatology
Cost Effectiveness of Pharmacogenetic-Guided Clozapine Administration Based on Risk of HLA Variants in Japan and the UK · July 2021
Articles
Translational Psychiatry
Cost-Effectiveness of an Educational Intervention to Reduce Potentially Inappropriate Medication · May 2022
Articles
Age and Ageing
Cost-Effectiveness Implications of Increasing the Efficiency of the Extended-Release Naltrexone Induction Process for the Treatment of Opioid Use Disorder: A Secondary Analysis · May 2021
Articles (Manuscripts-Versions)
PubMed Central>Addiction
Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-Based Mirror-Image Study in South Korea · May 2020
Articles
Clinical Psychopharmacology and Neuroscience
Cost-Effectiveness of Duloxetine for Knee OA Subjects: The Role of Pain Severity · November 2020
Articles (Manuscripts-Versions)
PubMed Central>Osteoarthritis and Cartilage
Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Cost-Effectiveness of Psilocybin-Assisted Therapy for Severe Depression: Exploratory Findings from a Decision Analytic Model · June 2023
Articles
Psychological Medicine
Healthcare Resource Utilization and Costs among Patients with Schizophrenia Switching from Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis · April 2020
Articles
Current Therapeutic Research
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis · September 2021
Articles
Journal of Alzheimer’s Disease Reports
Using Cost-Effectiveness Analysis to Support Policy Change: Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Jordan · October 2020
Articles
Journal of Pharmaceutical Policy and Practice
Real-World Clinical and Cost-Effectiveness of Community Clozapine Initiation: Mirror Cohort Study · April 2022
Articles
British Journal of Psychiatry
Cost-Per-Remitter with Esketamine Nasal Spray versus Standard of Care for Treatment-Resistant Depression · February 2021
Articles
Journal of Comparative Effectiveness Research
Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients · September 2022
Articles
Current Oncology
Healthcare Resource Utilization and Costs Before and After Long-Acting Injectable Antipsychotic Initiation in Commercially Insured Young Adults with Schizophrenia · April 2022
Articles
BMC Psychiatry
Assessing the Cost-Effectiveness of a Hypothetical Disease-Modifying Therapy with Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease · October 2022
Articles
Clinical Therapeutics
Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee OA Patients with Moderate Pain? A Cost-Effectiveness Analysis · November 2020
Articles (Manuscripts-Versions)
NCBI>Arthritis Care and Research